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Cardiac Troponin Elevation After
Percutaneous Coronary Intervention
An Ultrasound Analysis
Young Joon Hong, MD,* Gary S. Mintz, MD,† Sang Wook Kim, MD,*
Sung Yun Lee, MD,* Teruo Okabe, MD,* Augusto D. Pichard, MD,* Lowell F. Satler, MD,*
Ron Waksman, MD,* Kenneth M. Kent, MD, PHD,* William O. Suddath, MD,*
Neil J. Weissman, MD*
Washington, DC; and New York, New York
O B J E C T I V E S We used virtual histology–intravascular ultrasound (VH-IVUS) to study the relation-
ship between pre-percutaneous coronary intervention (PCI) coronary plaque characteristics and post-PCI
cardiac troponin I (cTnI) elevation.
B A C KG ROUND Percutaneous coronary intervention is often complicated by post-procedural
myocardial necrosis as manifested by elevated cardiac markers.
METHOD S Eighty consecutive patients (29 stable and 51 unstable angina) with normal pre-PCI cTnI
levels were imaged before PCI using VH-IVUS. Patients were divided into 2 groups according to the
presence (Group I, n  38) or absence (Group II, n  42) of post-PCI cTnI elevation 3 the upper limit
of normal (0.08 ng/ml).
R E S U L T S The absolute and percent necrotic core volumes were signiﬁcantly greater in Group I than
in Group II (13.6  6.4 mm3 vs. 7.9  4.4 mm3, p  0.001, and 19.8  10.4% vs. 12.8  8.4%, p  0.015,
respectively). The absolute and percent necrotic core areas were signiﬁcantly greater in Group I than in
Group II at the minimum lumen site (1.70 0.91 mm2 vs. 0.61 0.39 mm2, p 0.001, and 22.9 11.7%
vs. 10.4  6.6%, p  0.001, respectively) and at the largest necrotic core site (2.00  0.86 mm2 vs. 0.81
 0.78 mm2, p 0.001, and 24.0 11.7% vs. 12.9 6.6%, p 0.001, respectively). The ∆cTnI correlated
with: 1) absolute and percent necrotic core area at the minimum lumen site and at the largest necrotic
core site; 2) absolute necrotic core volume; 3) percent ﬁbrofatty area at the minimum lumen site; and
4) lesion site plaque burden. In the multivariate analysis, absolute necrotic core area at the minimum
lumen site was the only independent predictor of post-PCI cTnI elevation3 the upper limit of normal
(odds ratio: 1.318; 95% conﬁdence interval: 1.090 to 1.594, p  0.004).
CONC L U S I O N S The VH-IVUS analysis shows that post-PCI cTnI elevation occurs in lesions with a
large necrotic core area. The VH-IVUS may play an important role in detecting which lesions are high
risks for myocardial necrosis after PCI. (J Am Coll Cardiol Img 2009;2:458–68) © 2009 by the American
College of Cardiology Foundation
From the *Cardiovascular Research Institute/Medstar Research Institute, Washington Hospital Center, Washington, DC; and
the †Cardiovascular Research Foundation, New York, New York.Manuscript received June 13, 2008; revised manuscript received December 2, 2008, accepted December 19, 2008.
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459ardiac troponin I (cTnI) is a sensitive and
specific marker for detecting subtle de-
grees of myocardial damage (1–3). Ele-
vated hospital admission troponin levels
re associated with increased cardiac events in
atients presenting with acute coronary syndromes
4–11). Percutaneous coronary intervention (PCI)
ay be complicated by myocardial necrosis as
anifested by troponin elevation (12–17). In pa-
ients with normal admission cTnI levels, post-PCI
TnI elevation has been associated with increased
hort-term and mid-term cardiac events (16–18).
See page 469
Intravascular ultrasound (IVUS) is widely used to
ssess coronary artery morphometry. However, gray-
cale IVUS has significant limitations in assessing
laque composition (19,20). Spectral analysis of IVUS
adiofrequency data (virtual histology [VH]-IVUS)
ay provide quantitative information on plaque com-
osition; it has been validated in studies of explanted
uman coronary segments (21). A VH-IVUS charac-
erizes atherosclerotic plaque as fibrotic, fibrofatty,
ense calcium, and necrotic core (21,22).
So far, no studies have shown a relationship
etween plaque composition and post-PCI biomar-
er levels. Therefore, the purpose of the present
tudy was to investigate the impact of pre-PCI
oronary plaque compositions, as determined by
H-IVUS, on post-PCI cTnI elevation.
E T H O D S
atient population. From our catheterization lab-
ratory database, we retrospectively identified 80
atients (29 with stable angina and 51 with
nstable angina) without cTnI elevation at ad-
ission who underwent pre-PCI VH-IVUS of a
ingle, native, de novo coronary lesion. We ex-
luded patients with acute ST-segment elevation
yocardial infarction within 72 h, or elevated
aseline pre-PCI cTnI, or patients who were
reated with atheroablative devices or with poor-
uality VH-IVUS. Overall, 90% of the patients
eceived aspirin, and all patients received clopi-
ogrel before PCI. Patients with acute myocar-
ial infarction on admission, patients with mul-
ivessel or multilesion PCI, and patients who
ere treated with atheroablative or distal protec-
ion devices were excluded from this study. The
rotocol was approved by the institutional review
oard. Hospital records of patients were reviewed
o obtain information on clinical demographics. ETnI analysis. Venous blood samples were obtained
ithin 1 h before PCI and within 24 h after PCI.
he blood samples were centrifuged, and serum was
emoved and stored at 70°C until the assay could
e performed. The cTnI levels were measured by a
aramagnetic particle, chemiluminescent immu-
oenzymatic assay (Beckman Coulter Inc., Fuller-
on, California). The manufacturer’s suggested up-
er normal cutoff value was 0.08 ng/ml. After PCI,
here were 32 patients with no cTnI elevation, 7
atients with cTnI elevation 2 the upper limit
f normal, 3 patients with cTnI elevation 3
he upper limit of normal, and 38 patients with
TnI elevation 3 the upper limit of normal.
atients were divided into 2 groups: post-PCI
TnI 3 the upper limit of normal (Group I)
ersus post-PCI cTnI 3 the upper limit of
ormal (Group II).
uantitative coronary angiography (QCA) analysis.
uantitative analysis (CAAS II, Pie Medical,
aastricht, the Netherlands) was performed using
tandard protocols (23). With the outer
iameter of the contrast-filled catheter as
he calibration standard, the minimal lu-
en diameter, reference diameter, and
esion length were measured in diastolic
rames from orthogonal projections. Films
ere recorded at 30 frames/s. The frame
ount was measured with a frame-counting
ine viewer. Corrected Thrombolysis In
yocardial Infarction (TIMI) frame count
as estimated as previously reported (24,25).
VUS imaging and analysis. All pre-PCI
H-IVUS examinations were performed after in-
racoronary administration of 200 g nitroglycerin.
2-MHz, 2.9-F IVUS imaging catheter (Eagle
ye, Volcano Corp., Rancho Cordova, California)
as advanced 10 mm beyond the lesion, and
utomated pullback was performed to a point 10
m proximal to the lesion at a speed of 0.5 mm/s.
Quantitative volumetric grayscale and VH-IVUS
nalysis was performed across the entire lesion seg-
ent, and cross-sectional analysis was performed at
he minimum lumen site and at the largest necrotic
ore site. Conventional quantitative volumetric gray-
cale IVUS analysis was performed according to the
merican College of Cardiology Clinical Expert
onsensus Document on Standards for Acquisition,
easurement, and Reporting of Intravascular Ultra-
ound Studies (26). External elastic membrane
EEM) and lumen cross-sectional areas (CSAs) were
easured. Plaque plus media CSA was calculated as
A B B
A N D
CSA
cTnI
EEM
memb
PCI
interv
VH-IV
intravEM minus lumen CSA, and plaque burdeR E V I A T I O N S
A C R O N YM S
cross-sectional area
cardiac troponin I
external elastic
rane
percutaneous coronary
ention
US virtual histology–n was
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460alculated as plaque plus media divided by EEM
SA. Proximal and distal references were the single
lices with the largest lumen and smallest plaque
urden within 10 mm proximally and distally, but
efore any large side branch. Coronary artery remod-
ling was assessed by comparing the lesion site to the
eference segment EEM CSA. Positive remodeling
as defined as a remodeling index (lesion site EEM
SA divided by the average of the proximal and distal
eference segment EEM CSA) 1.05, intermediate
emodeling as a remodeling index between 0.95 and
.05, and negative remodeling as a remodeling index
0.95 (27). The VH-IVUS analysis classified and
olor-coded tissue into 4 major components: green
fibrotic), yellow-green (fibrofatty), white (dense cal-
ium), and red (necrotic core) (21,22). The VH-IVUS
nalysis was reported in absolute amounts and as a
ercentage of plaque area or volume.
tatistical analysis. Statistical analysis was per-
ormed using SAS version 9.1 (SAS Institute Inc.,
ary, North Carolina). Continuous variables were
resented as the mean  1 SD; comparisons were
onducted by Student t test or nonparametric Wil-
oxon test if normality assumption was violated.
iscrete variables were presented as percentages
Table 1. Baseline Characteristics According to the Presence/Abs
Group
(cTnI Elevati
(n  3
Age (yrs) 63 
Male gender, n (%) 29 (76
Clinical presentation, n (%)
Stable angina 12 (32
Unstable angina 26 (68
Diabetes mellitus, n (%) 12 (32
Hypertension, n (%) 28 (74
Smoking, n (%) 15 (40
Pre-PCI aspirin use, n (%) 33 (89
Pre-PCI clopidogrel use, n (%) 38 (10
Clopidogrel loading, n (%)
None 7 (18
300 mg 12 (32
600 mg 19 (50
Bivalirudin use, n (%) 35 (92
Glycoprotein IIb/IIIa inhibitor use, n (%) 4 (11
Ejection fraction (%) 59 
Total cholesterol (mg/dl) 178 
Triglyceride (mg/dl) 123 
LDL cholesterol (mg/dl) 107 
HDL cholesterol (mg/dl) 46 
Data are presented as the n (%) of patients or mean  SD.
cTnI  cardiac troponin I; HDL  high-density lipoprotein; LDL  low-densitynd relative frequencies; comparisons were con- mucted by chi-square statistics or Fisher exact test as
ppropriate. A Spearman correlation coefficient was
sed if the normality assumption was not satisfied.
ultivariate logistic regression analysis was per-
ormed to identify independent predictors of post-
CI cTnI elevation 3 the upper limit of normal.
nivariate analyses were first conducted to identify
otential risk factors for post-PCI cTnI elevation
3 the upper limit of normal. The likelihood ratio
est was used, and the variables with a value of p 0.2
ere included in the multivariate model. Finally, a
tep-down logistic regression was performed, with
ost-PCI cTnI elevation 3 the upper limit of
ormal and the covariates that remained significant in
he previous analysis. The least significant variable was
ropped at each step until only covariates with a value
f p  0.05 remained. Receiver-operator characteris-
ics were generated from multiple sensitivity/
pecificity pairs. A value of p  0.05 was considered
tatistically significant.
E S U L T S
atient characteristics and angiographic and proce-
ural results. The baseline characteristics are sum-
e of Post-PCI cTnI Elevation >3 the Upper Limit of Normal
3)
Group II
(cTnI Elevation <3)
(n  42) p Value
65  11 0.4
20 (48) 0.009
0.4
17 (41)
25 (60)
10 (24) 0.4
27 (64) 0.4
18 (43) 0.8
39 (93) 0.4
42 (100) 1.0
0.012
1 (2)
8 (19)
33 (79)
37 (88) 0.6
6 (14) 0.6
59  8 0.8
156  40 0.041
116  60 0.6
88  34 0.063
44  11 0.3
protein; PCI  percutaneous coronary intervention.enc
I
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461ance and higher total cholesterol level in Group
compared with Group II. Although there were
o significant differences in the pre-PCI use of
spirin and clopidogrel between the 2 groups,
ore Group II patients received clopidogrel
oading compared with Group I; and a higher
oading dose of clopidogrel was used in Group II
ompared with Group I.
Angiographic findings and procedural results
re summarized in Table 2. All lesions were treated
ith stent implantation: 54 lesions with sirolimus-
luting stents, 17 lesions with paclitaxel-eluting
tents, and 9 lesions with bare-metal stents.
here was no significant difference in the inci-
ence of bifurcation lesion between both groups
11% in Group I vs. 5% in Group II, p  0.4).
ost-PCI TIMI flow grade 0/1 was observed
ore frequently in Group I compared with
roup II (11% vs. 0%, p  0.047), and post-PCI
orrected TIMI frame count was significantly
igher in Group I compared with Group II (24 
Table 2. Coronary Angiographic Findings and Procedural Result
>3 the Upper Limit of Normal
Group I
(cTnI Elevation
(n  38
Target vessel, n (%)
LAD 22 (58)
LCX 7 (18)
RCA 9 (23)
Lesion location, n (%)
Ostium 3 (8)
Proximal 11 (29)
Middle 21 (55)
Distal 3 (8)
Pre-PCI TIMI ﬂow grade 3 38 (100)
Bifurcation lesions, n (%) 12 (32)
Stent type, n (%)
Sirolimus-eluting stent 23 (61)
Paclitaxel-eluting stent 10 (26)
Bare-metal stent 5 (13)
Stent diameter (mm) 3.22  0.3
Stent length (mm) 24  10
Reference diameter (mm) 3.34  0.8
Pre-MLD (mm) 1.04  0.6
Post-MLD (mm) 3.17  0.6
Lesion length (mm) 16  8
Side branch occlusion, n (%) 4 (11)
Post-PCI TIMI ﬂow grade 0/1 4 (11)
Post-PCI corrected TIMI frame count 24  10
Data are presented as the n (%) of patients or mean  SD.
LAD left anterior descending artery; LCX left circumﬂex artery; MLDmini
Infarction; other abbreviations as in Table 1.0 vs. 20  7, p  0.042). There was no edge gissection, which needs additional stent implan-
ation, in both groups and there was no signifi-
ant difference in the incidence of side branch
cclusion between the 2 (post-PCI cTnI) groups.
onventional IVUS and VH-IVUS results. An example
f VH-IVUS is shown in Figure 1. Conventional
VUS findings are summarized in Table 3. There
ere strong trends for a smaller minimum lumen
rea and a larger plaque burden at the minimum
umen site and at the largest necrotic core site in
roup I compared with Group II. Positive re-
odeling was more common and the remodeling
ndex was significantly higher in Group I than in
roup II.
The absolute and percent necrotic core vol-
mes were significantly greater in Group I (those
ith significant increases in cTnI) than in Group
I; conversely absolute and percent fibrofatty
laque volume were significantly smaller in
roup I than in Group II (Fig. 2). The absolute
nd percent necrotic core areas were significantly
ccording to the Presence/Absence of Post-PCI cTnI Elevation
)
Group II
(cTnI Elevation <3)
(n  42) p Value
0.14
22 (52)
3 (7)
17 (41)
0.9
2 (5)
12 (29)
23 (55)
5 (12)
42 (100) 1.0
10 (24) 0.4
0.4
31 (74)
7 (17)
4 (10)
3.18  0.42 0.7
22  6 0.4
3.30  0.75 0.3
1.10  0.53 0.2
3.12  0.70 0.3
14  5 0.2
2 (5) 0.4
0 (0) 0.047
20  7 0.042
umen diameter; RCA right coronary artery; TIMI Thrombolysis In Myocardials A
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462inimum lumen site and at the largest necrotic
ore site. Absolute fibrotic area was significantly
reater in Group I than in Group II at the
inimum lumen site, and percent fibrofatty area
as significantly smaller in Group I than in
roup II at the minimum lumen site and at the
argest necrotic core site (Fig. 3).
orrelations between cTnI level and grayscale and
H-IVUS parameters. The cTnI level correlated
ith: 1) absolute necrotic core area (r  0.419, p 
.001) and percent necrotic core area (r  0.310,
 0.005) at the minimum lumen site; 2) abso-
ute necrotic core area (r  0.336, p  0.002) and
ercent necrotic core area (r  0.238, p  0.034) at
he largest necrotic core site; 3) absolute necrotic
ore volume (r  0.347, p  0.002); 4) percent
brofatty area at the minimum lumen site (r 
0.270, p  0.015); and 5) lesion site plaque
urden (r  0.248, p  0.027) (Fig. 4). There were
o correlations between cTnI level versus the
Figure 1. Pre-Interventional Imaging With Virtual Histology
(A) Pre-percutaneous coronary intervention (PCI) coronary angiogra
stent implantation (arrow indicates no residual stenosis); (C) pre-PC
intravascular ultrasound in the middle portion of the left circumﬂexther grayscale or VH-IVUS parameters. andependent predictors of post-PCI cTnI elevation.
ultiple logistic regression analysis was per-
ormed to determine independent predictors of
ost-PCI cTnI elevation 3 the upper limit of
ormal. All variables with p  0.2 in univariate
nalysis were tested. Absolute necrotic core area
t the minimum lumen site was the only inde-
endent predictor of post-PCI cTnI elevation
3 upper limit of normal (odds ratio: 1.318; 95%
onfidence interval: 1.090 to 1.594, p  0.004).
he area under the receiver-operator characteristic
urve for absolute necrotic core area at the mini-
um lumen site predicting post-PCI cTnI eleva-
ion 3 upper limit of normal was 0.914 (Fig. 5).
I S C U S S I O N
he present VH-IVUS study showed a direct
elationship between pre-PCI plaque composition
rrow indicates signiﬁcant stenosis); (B) coronary angiogram after
yscale intravascular ultrasound; and (D) pre-PCI virtual histology-
ery.m (a
I grand post-PCI myonecrosis. In particular, post-PCI
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463TnI elevation 3 normal was predicted by a
arger necrotic core area at the minimum lumen site.
The marker cTnI is sensitive and specific for
etecting subtle myocardial damage (1–3). In
atients with non–ST-segment elevation acute
oronary syndrome, increased pre-PCI cTnI and
ardiac troponin T levels have been associated
ith increased short-term and intermediate-term
ardiac events (4 –11). Post-PCI cTnI elevation
as been associated with increased short-term
nd intermediate-term adverse cardiac events in
atients without elevation of pre-PCI cTnI levels
16–18). The pathophysiology of myocardial necro-
is during PCI has been related to development of
o-reflow, side branch occlusion, abrupt vessel clo-
ure, and atherothrombotic or platelet embolization
28–30). Kotani et al. (31) reported that no-reflow
uring PCI in patients with acute coronary syn-
romes is attributable not just to the thrombus
urden, but also to plaque components of the
theromatous lesions. They concluded that no-
Table 3. Grayscale IVUS Findings According to the Presence/Ab
Group I
(cTnI Elevation >3
(n  38)
Reference
EEM CSA (mm2) 15.8 4.7
Lumen CSA (mm2) 9.2 3.0
P&M CSA (mm2) 6.6 2.8
Plaque burden (%) 41 10
Minimum lumen site
EEM CSA (mm2) 16.2 4.4
Lumen CSA (mm2) 3.7 0.8
P&M CSA (mm2) 12.5 4.4
Plaque burden (%) 77 8
Lesion length (mm) 18 9
Largest necrotic core site
EEM CSA (mm2) 16.4 4.2
Lumen CSA (mm2) 4.8 1.9
P&M CSA (mm2) 11.6 3.5
Plaque burden (%) 71 9
Volumetric analysis (mm3)
EEM volume 170.0 102.8
Lumen volume 59.8 24.8
P&M volume 110.2 55.1
Remodeling pattern, n (%)
Positive remodeling 20 (53)
Intermediate remodeling 9 (24)
Negative remodeling 9 (24)
Remodeling index 1.03 0.15
Data are presented as the n (%) of patients or mean  SD.
CSA  cross-sectional area; EEM  external elastic membrane; IVUS  intravaeflow may be caused by “gruel” embolized from an ptheroma attributable to mechanical plaque disrup-
ion during intervention, suggesting that pre-PCI
laque composition may have an impact on myo-
ecrosis during intervention.
However, there are few published data regarding
he relationship between pre-PCI lesion subsets
nd post-PCI biomarker levels. Kini et al. (32)
eported that pre-PCI angiographic predictors of
reatine kinase-MB elevation were diffuse coronary
isease, type C lesion according to the American
ollege of Cardiology/American Heart Association
lassification, and multivessel disease. Fujii et al.
33) compared creatine kinase-MB release after
tent implantation in 62 patients with IVUS-
etected ruptured plaques with 62 matched control
atients; patients with ruptured plaques had higher
reatine kinase-MB release rates than control pa-
ients, and independent predictors of post-PCI
reatine kinase-MB elevation were presence of rup-
ured plaque and unstable angina. Prati et al. (34)
eported that a marked post-stenting reduction in
e of Post-PCI cTnI Elevation >3 the Upper Limit of Normal
Group II
(cTnI Elevation <3)
(n  42) p Value
15.4 5.0 0.7
9.2 3.2 1.0
6.2 2.6 0.6
40 9 0.6
15.2 5.0 0.3
4.0 0.9 0.051
11.2 4.4 0.19
74 7 0.065
16 7 0.4
16.0 5.0 0.7
5.1 2.2 0.068
10.9 3.9 0.19
68 9 0.079
160.7 97.6 0.4
60.8 22.3 0.8
99.9 48.5 0.3
0.046
11 (26)
18 (43)
13 (31)
0.99 0.12 0.038
ar ultrasound; P&M  plaque plus media; other abbreviations as in Table 1.senc
)laque volume, which was significantly greater in
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464nstable angina lesions than in stable angina le-
ions, was associated with post-procedural creatine
inase-MB release. Mehran et al. (35) studied
,256 consecutive patients who underwent PCI of
,780 native coronary lesions and had pre-PCI
VUS imaging; both a greater lesion and reference
egment plaque burden were associated with post-
CI creatine kinase-MB elevation.
Recently, several studies have shown the relation-
hip between VH-IVUS findings and post-PCI
istal embolization (36,37). Kawaguchi et al. (36)
nvestigated high-risk plaque of distal embolization
fter stent deployment in patients with acute ST-
Absolute plaque volume
.15
p=0.038
p=0.2
otic Fibrofatty Dense calcium Necrotic core
p<0.001
Relative plaque volume
.5
p=0.031
p=0.2
tic Fibrofatty Dense calcium Necrotic core
p=0.015
Virtual Histology Plaque Component Analysis
logy plaque component analysis according to the presence or
taneous coronary intervention cardiac troponin I (cTnI) elevation
re shown for (A) absolute and (B) relative quantiﬁcations. The
ecrotic core volume was signiﬁcantly greater (13.6  6.4 mm3 vs.
10.4% vs. 12.8  8.4%); conversely absolute and percent ﬁbro-
as signiﬁcantly smaller (13.1  9.9 mm3 vs. 16.9  11.6 mm3, 19.0
%) in patients with cTnI elevation 3 the upper limit of normal.egment elevation myocardial infarction with VH- sVUS, and they showed that necrotic core volume
learly predicted ST-segment re-elevation, which
as used to evaluate distal embolization in this
tudy after stent deployment as compared with
brous, fibro-lipid, dense calcium, and total plaque
olumes. Kawamoto et al. (37) investigated the
elationship between coronary plaque components
nd small embolic particles during stenting and
xamined the influence on the coronary microcir-
ulation using VH-IVUS, and they showed that the
ecrotic core component identified with VH-IVUS
as related to liberation of small embolic particles
uring coronary stenting, which resulted in the
oorer recovery of coronary flow velocity reserve.
In the present study, post-PCI myocardial injury
ccurred in lesions with a large necrotic core area [this
esult is consistent with previous VH-IVUS studies by
awaguchi et al. (36) and by Kawamoto et al. (37)],
specially in lesions with a large absolute necrotic core
rea at the minimum lumen site. The derived effect
ize (using the Cohen d approximation) of the differ-
nce in absolute necrotic core area at the minimum
umen site between the 2 (post-PCI cTnI) groups
ould equal 1.71 (95% confidence interval: 1.42 to
.83). Different people offer different advice regarding
ow to interpret the resultant effect size, but the most
ccepted opinion is that of Cohen, in which 0.2 is
ndicative of a small effect, 0.5 a medium, and 0.8 a
arge effect. Therefore, this effect size of 1.71 in the
resent study is very large and suggests that there is a
onsistent difference in the absolute necrotic core area
t the minimum lumen site, on average, between the
(post-PCI cTnI) groups.
Selvanayagam et al. (38) showed 2 types of
yocardial injury after PCI using magnetic reso-
ance imaging. They investigated the quantitative
elationship between irreversible injury and cTnI
elease, and they showed that patients demonstrat-
ng post-procedural elevation in cTnI have evidence
f new irreversible myocardial injury on delayed-
nhancement magnetic resonance imaging and the
agnitude of this injury correlates directly with the
xtent of cTnI elevation. They indicated that there are
distinct sites of new hyperenhancement; the major-
ty of patients showed new irreversible injury in a
reviously normal area in the apical myocardium,
hich likely represents new myocardial necrosis
esulting from distal embolization of particulate
atter during balloon inflation and stenting, and
n the remaining patients with new hyperen-
ancement, it was located in the basal or mid-
entricular myocardium, adjacent to the insertedA
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465ow impairment/occlusion. In the present study,
ost-PCI TIMI flow grade 0/1 was observed
ore frequently and post-PCI corrected TIMI
rame count was significantly higher in patients
ith post-PCI cTnI elevation; however, there
as no difference in the incidence of side branch
cclusion between the 2 (post-PCI cTnI) groups.
In the present study, there was also a strong
elationship between a larger lesion site plaque
urden and post-PCI cTnI elevation. However, the
esion site plaque burden was not an independent
redictor of post-PCI cTnI elevation once plaque
omposition was considered. The size of the ne-
rotic core may be the link between plaque burden
nd post-PCI myonecrosis. In fact, in the current
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Figure 3. Cross-Sectional Virtual Histology Plaque Component A
Cross-sectional virtual histology plaque component analysis at the min
according to the presence or absence of post-percutaneous coronary i
shown for (A, C) absolute and (B, D) relative quantiﬁcations. At the mi
signiﬁcantly greater (1.70  0.91 mm2 vs. 0.61  0.39 mm2, 4.79  2.3
cantly greater (22.9  11.7% vs. 10.4  6.6%), and percent ﬁbrofatty a
with cTnI elevation 3 normal. At the largest necrotic core site, (C) a
0.81  0.78 mm2); (D) percent necrotic core area was signiﬁcantly grea
niﬁcantly smaller (15.4  8.3% vs. 22.0  13.6%) in patients with cTnInalysis, the absolute necrotic core area correlated sith the plaque burden at the minimum lumen site
r  0.286, p  0.010).
Kotani et al. (31) compared the aspirated mate-
ials between the lesions with no-reflow to those
ithout no-reflow using a thrombectomy device. In
heir study, all aspirates after PCI contained platelet
ggregates or fibrin–platelet complexes, suggesting
hat glycoprotein IIb/IIIa inhibitors may attenuate
he complications during PCI for acute coronary
yndrome patients. Therefore, if a large necrotic
ore at the minimum lumen site is observed before
CI, one may consider using glycoprotein IIb/IIIa
nhibitors during PCI to potentially reduce the
ost-PCI myocardial injury.
tudy limitations. First, this study is based on a
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was signiﬁcantly smaller (14.2  8.3% vs. 26.5  13.6%) in patients
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Figure 4. Correlations to Cardiac Troponin Level
Correlations of ∆cardiac troponin I level and (A) absolute necrotic core area at the minimum lumen site, (B) percent necrotic core area at
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necrotic core site, (E) absolute necrotic core volume, (F) percent ﬁbrofatty area at the minimum lumen site, and (G) lesion site plaque
burden.
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467f selection bias. Second, this was a retrospective
ingle-center study. The results of this study
hould be verified by further prospective investi-
ation. Third, although patients with post-PCI
TnI elevation received lower use of the high
oading dose of clopidogrel, the fact remains that
higher dose of clopidogrel loading was not a
ignificant predictor of post-PCI cTnI elevation
y multivariate analysis. This is inconsistent with
he results of the ARMYDA-2 (Antiplatelet
herapy for Reduction of MYocardial Damage
uring Angioplasty) study (39), which showed
hat pre-treatment with a 600-mg loading dose of
lopidogrel 4 to 8 h before the procedure was safe
nd, as compared with the conventional 300-mg
ose, significantly reduced periprocedural myo-
ardial infarction in patients undergoing PCI.
he difference between the results of the AR-
YDA study and those of the present study may
e attributable to the possible selection bias and
he small study size in the present study. Fourth,
he cTnI level was not measured serially after
tent implantation, and we did not measure the
TnI level at the same time after stent implanta-
ion in all patients. Fifth, we did not attempt to
ifferentiate between atherosclerotic plaque and
hrombus because VH-IVUS could not deter-
ine the presence of thrombus.
O N C L U S I O N S
he present VH-IVUS study showed that post-J Med 2000;343:1139–47. measures for early aecrotic core. The VH-IVUS analysis may be a
seful modality for detecting lesions at risk for
yocardial necrosis during PCI.
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